Logo image of ZKIN

ZK INTERNATIONAL GROUP CO LT (ZKIN) Stock Fundamental Analysis

NASDAQ:ZKIN - Nasdaq - VGG9892K1003 - Common Stock - Currency: USD

0.389  -0.1 (-19.88%)

After market: 0.386 0 (-0.77%)

Fundamental Rating

1

Overall ZKIN gets a fundamental rating of 1 out of 10. We evaluated ZKIN against 152 industry peers in the Metals & Mining industry. ZKIN may be in some trouble as it scores bad on both profitability and health. ZKIN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ZKIN has reported negative net income.
ZKIN had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ZKIN reported negative operating cash flow in multiple years.
ZKIN Yearly Net Income VS EBIT VS OCF VS FCFZKIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

ZKIN has a Return On Assets of -79.62%. This is amonst the worse of the industry: ZKIN underperforms 96.55% of its industry peers.
With a Return On Equity value of -216.36%, ZKIN is not doing good in the industry: 93.79% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -79.62%
ROE -216.36%
ROIC N/A
ROA(3y)-37.22%
ROA(5y)-20.45%
ROE(3y)-84.98%
ROE(5y)-47.62%
ROIC(3y)N/A
ROIC(5y)N/A
ZKIN Yearly ROA, ROE, ROICZKIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200

1.3 Margins

Looking at the Gross Margin, with a value of 1.29%, ZKIN is doing worse than 66.90% of the companies in the same industry.
ZKIN's Gross Margin has declined in the last couple of years.
ZKIN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.29%
GM growth 5Y-48.9%
ZKIN Yearly Profit, Operating, Gross MarginsZKIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

More info and screens

2

2. Health

2.1 Basic Checks

ZKIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZKIN has been increased compared to 1 year ago.
ZKIN has more shares outstanding than it did 5 years ago.
ZKIN has a worse debt/assets ratio than last year.
ZKIN Yearly Shares OutstandingZKIN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
ZKIN Yearly Total Debt VS Total AssetsZKIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

ZKIN has an Altman-Z score of 0.91. This is a bad value and indicates that ZKIN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.91, ZKIN is not doing good in the industry: 75.17% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.44 indicates that ZKIN is not too dependend on debt financing.
ZKIN has a worse Debt to Equity ratio (0.44) than 74.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z 0.91
ROIC/WACCN/A
WACC7.53%
ZKIN Yearly LT Debt VS Equity VS FCFZKIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.55 indicates that ZKIN should not have too much problems paying its short term obligations.
ZKIN's Current ratio of 1.55 is on the low side compared to the rest of the industry. ZKIN is outperformed by 73.10% of its industry peers.
ZKIN has a Quick Ratio of 1.22. This is a normal value and indicates that ZKIN is financially healthy and should not expect problems in meeting its short term obligations.
ZKIN has a Quick ratio (1.22) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.22
ZKIN Yearly Current Assets VS Current LiabilitesZKIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for ZKIN have decreased strongly by -837.70% in the last year.
Looking at the last year, ZKIN shows a small growth in Revenue. The Revenue has grown by 5.20% in the last year.
The Revenue has been growing by 15.24% on average over the past years. This is quite good.
EPS 1Y (TTM)-837.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-741.76%
Revenue 1Y (TTM)5.2%
Revenue growth 3Y8.74%
Revenue growth 5Y15.24%
Sales Q2Q%6.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZKIN Yearly Revenue VS EstimatesZKIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
ZKIN Yearly EPS VS EstimatesZKIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ZKIN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZKIN Price Earnings VS Forward Price EarningsZKIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZKIN Per share dataZKIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZKIN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZK INTERNATIONAL GROUP CO LT

NASDAQ:ZKIN (1/30/2025, 6:00:59 PM)

After market: 0.386 0 (-0.77%)

0.389

-0.1 (-19.88%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)10-01 2024-10-01
Earnings (Next)N/A N/A
Inst Owners0.15%
Inst Owner Change0%
Ins Owners23.5%
Ins Owner ChangeN/A
Market Cap14.06M
Analysts0
Price TargetN/A
Short Float %0.79%
Short Ratio2.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.52
EV/EBITDA N/A
EPS(TTM)-1.89
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.18
BVpS0.79
TBVpS0.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -79.62%
ROE -216.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.29%
FCFM N/A
ROA(3y)-37.22%
ROA(5y)-20.45%
ROE(3y)-84.98%
ROE(5y)-47.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.29%
GM growth 5Y-48.9%
F-ScoreN/A
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.22
Altman-Z 0.91
F-ScoreN/A
WACC7.53%
ROIC/WACCN/A
Cap/Depr(3y)193.53%
Cap/Depr(5y)213.76%
Cap/Sales(3y)2.09%
Cap/Sales(5y)1.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-837.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-741.76%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.2%
Revenue growth 3Y8.74%
Revenue growth 5Y15.24%
Sales Q2Q%6.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-481.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.93%
OCF growth 3YN/A
OCF growth 5YN/A